• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 9, Issue 2
  3. Author

Online ISSN: 2515-8260

Volume9, Issue2

Radiological study of characterization of interstitial lung disease using HRCT in clinically suspected cases

    Dr. Deepak D Vyas, Dr. Ravi Varma, Dr. Sharad B Ghatge, Dr. Pooja D Vyas

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 2, Pages 1328-1334

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Background: Interstitial lung diseases are heterogeneous group of disorders of the lower respiratory tract that are characterized by both acute and chronic inflammation and a generally irreversible and relentless process of fibrosis in the interstitium and the alveolar walls. High-resolution computed tomography of the chest has become an invaluable tool in the diagnostic process of interstitial lung diseases. Present study was aimed to study characteristics of interstitial lung disease using HRCT in clinically suspected cases.
Material and Methods: Present study was single-center, cohort descriptive and observational study conducted in patients of any age, gender, with clinically suspected interstitial lung disease referred for HRCT.
Results: Majority of patients were found in the age group of 60-69 years (45%), were male (65%) & had history of smoking (42.5%). Major chief complaints were cough (55%), breathlessness (25%), dry cough (15%) and cough with fever (5%). Out of total of 40 patients, 22(55%) patients showed HRCT pattern reflecting Usual Interstitial Pneumonia (UIP) and Idiopathic Pulmonary Fibrosis (IPF), 10(25%) patients showed Nonspecific Interstitial Pneumonia (NSIP), 5(12.5%) patients had Hypersensitivity Pneumonitis (HSP) as well as 2(5%) patients had cryptogenic organizing pneumonia (COP) while only 1 patient (2.5%) showed changes of respiratory bronchiolitis-associated interstitial lung disease (RB-ILD). Maximum no of patients had bronchiectasis (57.50%), reticulation (42.50%), honeycombing (35.00%), ground glass opacities (32.50%) & consolidation (5.00%). Out of total of 40 patients, only 2 (9.09%) patient shows regression in UIP in follow-up scan, while others show progression 20(90.91%). 3 each shows progression in HSP (60%) and NSIP (30%), however in COP(100%) all patients show regression.
Conclusion: Based on the HRCT features a histospecific diagnosis can be reached in most cases of Idiopathic Interstitial Pneumonias obviating the need for biopsy.
Keywords:
    High resolution computed tomography (HRCT) idiopathic interstitial Pneumonias disease activity. Interstitial lung disease
  • PDF (378 K)
  • XML
(2022). Radiological study of characterization of interstitial lung disease using HRCT in clinically suspected cases. European Journal of Molecular & Clinical Medicine, 9(2), 1328-1334.
Dr. Deepak D Vyas, Dr. Ravi Varma, Dr. Sharad B Ghatge, Dr. Pooja D Vyas. "Radiological study of characterization of interstitial lung disease using HRCT in clinically suspected cases". European Journal of Molecular & Clinical Medicine, 9, 2, 2022, 1328-1334.
(2022). 'Radiological study of characterization of interstitial lung disease using HRCT in clinically suspected cases', European Journal of Molecular & Clinical Medicine, 9(2), pp. 1328-1334.
Radiological study of characterization of interstitial lung disease using HRCT in clinically suspected cases. European Journal of Molecular & Clinical Medicine, 2022; 9(2): 1328-1334.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 37
  • PDF Download: 91
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus